|
KTELC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.614100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.959000E-01 |
| Normal-vs-Stage2 |
1.193560E-01 |
| Normal-vs-Stage3 |
3.465000E-01 |
| Normal-vs-Stage4 |
8.279200E-01 |
| Stage1-vs-Stage2 |
1.267960E-01 |
| Stage1-vs-Stage3 |
6.523600E-01 |
| Stage1-vs-Stage4 |
9.572400E-01 |
| Stage2-vs-Stage3 |
3.507400E-01 |
| Stage2-vs-Stage4 |
4.014200E-01 |
| Stage3-vs-Stage4 |
7.588800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.097370E-01 |
| Normal-vs-AfricanAmerican |
4.268800E-01 |
| Normal-vs-Asian |
5.169600E-01 |
| Caucasian-vs-AfricanAmerican |
5.383000E-01 |
| Caucasian-vs-Asian |
9.292800E-01 |
| AfricanAmerican-vs-Asian |
8.905800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.621600E-01 |
| Normal-vs-Female |
5.540800E-03 |
| Male-vs-Female |
1.065940E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.175000E-01 |
| Normal-vs-Extreme_Weight |
3.863800E-01 |
| Normal-vs-Obese |
2.719000E-01 |
| Normal-vs-Extreme_Obese |
2.580200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.548800E-01 |
| Normal_Weight-vs-Obese |
8.855800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.559440E-01 |
| Extreme_Weight-vs-Obese |
8.237400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.225000E-01 |
| Obese-vs-Extreme_Obese |
7.778500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.525900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.307800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.030800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.675800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.913400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.876370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.212500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.518560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.826970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.128200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.106610E-01 |
| Normal-VS-Type2 PRCC |
1.841240E-01 |
| Normal-VS-KIRP CIMP |
1.252580E-01 |
| Normal-VS-Unclassified PRCC |
5.782100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.17299999999421E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.962400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.505000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.081800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.558100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.346000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.457600E-01 |
| Normal-vs-N1 |
2.907200E-01 |
| Normal-vs-N2 |
5.258000E-01 |
| N0-vs-N1 |
1.342810E-01 |
| N0-vs-N2 |
4.817800E-01 |
| N1-vs-N2 |
4.889600E-01 |
|
|
